FMT Capsules for rCDI

Abroad (travel likely)RecruitingPHASE3

Conditions

Clostridioides Difficile Infection Recurrence · FMT

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Helsinki University Hospital, Helsinki, Uusimaa, Finland
Contact: Study coordinator (Perttu Arkkila, Professor) · perttu.arkkila@hus.fi · +358504272272

Study leads

Perttu Arkkila, Professor
Principal Investigator
Helsinki University Central Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Secondary Prevention of Clostridioides Difficile Using Vancomycin

Clostridioides Difficile Infection · Clostridioides Difficile Infection Recurrence · Clostridoides Difficile Associated Disease

Abroad (travel likely)RecruitingPHASE2, PHASE3

Montreal, Canada

LMN-201 for Prevention of C. Difficile Infection Recurrence

Clostridioides Difficile Infection

Abroad (travel likely)RecruitingPHASE2, PHASE3

Escondido, United States · Bridgeport, United States

Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody

Clostridioides Difficile Infection

Abroad (travel likely)RecruitingPHASE2

Phoenix, United States · Chula Vista, United States

Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in High-risk Patients

Clostridioides Difficile Infection · Recurrent Infection

Abroad (travel likely)RecruitingPHASE1, PHASE2

Annecy, France · Clermont-Ferrand, France